H. KAYA Et Al. , "Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure," TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1, pp.22-28, 2017
KAYA, H. Et Al. 2017. Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure. TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1 , 22-28.
KAYA, H., KURT, R., BETON, O., ZORLU, A., YÜCEL, H., Gunes, H., ... Oguz, D.(2017). Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure. TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1, 22-28.
KAYA, HAKKI Et Al. "Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure," TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1, 22-28, 2017
KAYA, HAKKI Et Al. "Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure." TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1, pp.22-28, 2017
KAYA, H. Et Al. (2017) . "Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure." TEXAS HEART INSTITUTE JOURNAL , vol.44, no.1, pp.22-28.
@article{article, author={HAKKI KAYA Et Al. }, title={Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure}, journal={TEXAS HEART INSTITUTE JOURNAL}, year=2017, pages={22-28} }